Contra Zynerba Pharmac
13F holders, Q2 2025 (June 30)2holders +1
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Contra Zynerba Pharmac in their 13F filings, up 1 from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were Financial Gravity Companies, Inc. ($0) and First Command Advisory Services, Inc. ($0).
- Company
- Contra Zynerba Pharmac
- CUSIP
- 989CVR022
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 100 shares bought, net +100 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Financial Gravity Companies, Inc. | 0.00% | — | 3,600 | $0 |
| First Command Advisory Services, Inc. | 0.00% | Add +0.0% | 100 | $0 |
"% of holder's portfolio" is CONTRA ZYNERBA PHARMAC's weight in each manager's 13F, not the share of Contra Zynerba Pharmac the manager owns.